Secondary and Tertiary Prevention: Medical Rehabilitation

DC ElementWertSprache
dc.contributor.authorFieten, K.B.
dc.contributor.authorJohn, S.M.
dc.contributor.authorNowak, D.
dc.date.accessioned2021-12-23T16:34:35Z-
dc.date.available2021-12-23T16:34:35Z-
dc.date.issued2022
dc.identifier.issn01712004
dc.identifier.urihttps://osnascholar.ub.uni-osnabrueck.de/handle/unios/18134-
dc.description.abstractAllergies are a major public health burden, and targeted measures are required in terms of prevention and treatment. The most common allergic conditions encompass atopic dermatitis (AD), food allergy (FA), allergic asthma (AA), and allergic rhino-conjunctivitis (AR). Primary prevention aims at preventing the onset of allergic disease, before the disease process begins. Secondary prevention aims at preventing progression and exacerbation of allergic disease whereas tertiary prevention aims at reducing disease burden in patients with established disease, by allergen immunotherapy (AIT) or medical rehabilitation. Rehabilitation programs are used for treatment of AA and AD and usually consist of extensive patient assessment, optimization of treatment management, patient education, and behavioral interventions, ideally involving a multidisciplinary treatment team and sometimes provided in a specific climate, usually alpine or maritime. Similarly, prevention of occupational skin diseases requires interdisciplinary approaches on the level of secondary and tertiary preventive intervention; if this is provided, then prevention programs have proven highly (cost-) effective. Unfortunately, the recently published Minimal Standards of Prevention of these dermatoses, underlining especially the importance of meticulous allergological diagnosis and subsequent multidisciplinary patient education, are so far being adhered to only in very few European countries. © 2021, Springer Nature Switzerland AG.
dc.language.isoen
dc.publisherSpringer Science and Business Media Deutschland GmbH
dc.relation.ispartofHandbook of Experimental Pharmacology
dc.subjectair pollution
dc.subjectAllergic disease
dc.subjectallergy
dc.subjectasthma
dc.subjectbehavior therapy
dc.subjectClimate
dc.subjectcost effectiveness analysis
dc.subjectdisease management
dc.subjecteczema
dc.subjecthospital patient
dc.subjecthuman
dc.subjectimmunotherapy
dc.subjectMultidisciplinary
dc.subjectmultidisciplinary team
dc.subjectoccupational eczema
dc.subjectOccupational skin disease
dc.subjectpatient assessment
dc.subjectpatient education
dc.subjectPrevention
dc.subjectpsychosocial intervention
dc.subjectRehabilitation
dc.subjectsecondary prevention
dc.subjecttertiary prevention
dc.subjectultraviolet radiation
dc.titleSecondary and Tertiary Prevention: Medical Rehabilitation
dc.typebook part
dc.identifier.doi10.1007/164_2021_511
dc.identifier.pmid34196810
dc.identifier.scopus2-s2.0-85119673055
dc.identifier.urlhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85119673055&doi=10.1007%2f164_2021_511&partnerID=40&md5=8b169ee723e8c6ca2aa14d2c6e33509a
dc.description.volume268
dc.description.startpage449
dc.description.endpage470
dcterms.isPartOf.abbreviationHandb. Exp. Pharmacol.
crisitem.author.orcid0000-0001-5406-9458-
crisitem.author.netidJoSw269-
Zur Kurzanzeige

Seitenaufrufe

2
Letzte Woche
0
Letzter Monat
0
geprüft am 06.06.2024

Google ScholarTM

Prüfen

Altmetric